［8］Baxter RC. The role of insulin-like growth factors and their binding protein in tumor hypoglycemia. Horm Res, 1996,46:195-201.

　　［9］Laron Z, Anin S, Klipper-Aurbach Y, et al. Effects of insulin-like growth factors on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet, 1992,339:1258-1261.

　　［10］Likitmaskul S, Watcharasindhu s, Angsusingha K, et al. IGF-Ⅰgeneration test in non-growth hormone deficient short children. Horm R es, 1998,49:52.

　　［11］Cheetham LD, Holly JMP, Clayton K, et al. The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes. Diabetic Med, 1995,12:885-862.

　　［12］Anton-Lewis U, Madigan T, Burguera B, et al. Tteatment of insulin-resistance diabetic ketoacidosis with insulin-like growth factor Ⅰ in an adolescent with insulin-dependent diabetes. N Engl J Med, 1992,327:853-857.

　　［13］Zenobi PD, Jacggi-Groisman SE, Riesen WF, et al. Insulin-like growth factor Ⅰ improves glucose and lipid metabolism in type Ⅰ diabetes mellitus. J Clin Invest, 1992,90:2234-2241.

　　［14］Moses AC, Young SCJ, Morrow LA, et al. Recombinant human insulin-like growth factor Ⅰ increases insulin sensitivity and improves glycemic control in type Ⅱ diabetes. Diabetes, 1996,45:91-100.

　　［15］Schoenle EJ, Zenobi PD, Torresani T, et al. Recombinant human insulin-like growth factor Ⅰ (IGF-Ⅰ) reduces hyperglycemia in patients with extreme insulin resistance. Diabetologia, 1991,34:675-679.

　　［16］Moses AC, Morrow LA, O’Brien M, et al. Insulin-like growth factor Ⅰ (rhIGF-Ⅰ) as a therape utic agent for hyperinsulinemic insulin-resistant diabetes mellitus. Diabetes Res Clin Pract, 1995,28:S185-195.

　　［17］Crowne EC, Samra JS, Cheetham T, et al. Recombinent human insulin-like growth factor-Ⅰ abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type Ⅰ diabetes mellitus. Metablism, 1998,47:31-38.

　　［18］Ishii DN. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Revi, 1995,20:47-67.

　　［19］Torresaleman I, Barrios V. Berciano J. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology, 1998,50:772-776.

　　［20］Roith DL. Insulin-like growth factors. N Engl J Med, 1997,336:633-640.

　　［21］Acerini CL, Patton CM, Savage MO, et al. Randomised placebo-controlled trial of human recombinant insulin-like growth factor-Ⅰ plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet, 1997,350:1199-1204.